| A Meta-Analysis into the Effects of Leptin Replacement Therapy on Metabolic and Hepatic Endpoints of Patients with Lipodystrophy Syndromes Not Associated with the Use of HIV … GJ Paz-Filho, T Neeman, CA Mastronardi, AJ Rodriguez ENDOCRINE REVIEWS 35 (3), 2014 | | 2014 |
| A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer’s disease D Sepulveda-Falla, L Chavez-Gutierrez, E Portelius, JI Vélez, S Dujardin, ... Acta neuropathologica 141, 217-233, 2021 | 41 | 2021 |
| A Mutation in DAOA Modifies the Age of Onset in PSEN1 E280A Alzheimer’s Disease JI Vélez, D Rivera, CA Mastronardi, HR Patel, C Tobón, A Villegas, Y Cai, ... Neural plasticity 2016 (1), 9760314, 2016 | 30 | 2016 |
| A Mutation in DAOA Modifies the Age of Onset in PSEN1 E280A Alzheimer´ s Disease FJ Lopera Restrepo, CA Tobón Quintero, CA Villegas Lanau, D Rivera, ... Hindawi Pub. Corp, 2016 | | 2016 |
| A novel oligogenetic framework identifies age of onset modifying mutations in Alzheimer’s disease JI Vélez, CA Mastronardi, HR Patel, AS Johar, F Lopera, M Arcos-Burgos | | |
| A tribute to Dr. Samuel McDonald McCann’s life as a scientist, mentor and friend CA Mastronardi, J Licinio, ML Wong Physiological Mini Reviews 4, 2009 | 1 | 2009 |
| aCentro de Estudios Farmacológicos, Consejo Nacional de Investigaciones Científicas y Técnicas (CEFYBO-CONICET), School of Medicine, UBA, Paraguay 2155 piso 16, 1121, Buenos … SM MCCANN, C MASTRONARDI, A DE LAURENTIIS, V RETTORIª Reversal of Aging: Resetting the Pineal Clock 1057, 64-84, 2005 | | 2005 |
| ADGRL3 (LPHN3) variants predict substance use disorder M Arcos-Burgos, JI Vélez, AF Martinez, M Ribasés, JA Ramos-Quiroga, ... Translational psychiatry 9 (1), 42, 2019 | 43 | 2019 |
| ADGRL3 (LPHN3) variants predict substance use disorder AB Mauricio, JI Vélez, AF Martinez, R Marta, JA Ramos-Quiroga, ... Translational Psychiatry 9 (1), 2019 | | 2019 |
| Antidepressants Restore the Long-Lasting Effects of Stress on Body Weight, and Those Effects are Associated With Leptin Levels ML Wong, S Lee, A Vincent, M Lewis, CA Mastronardi, J Licinio American College of Neuropsychopharmacology (ACNP) 56th Annual Meeting, 2017 | | 2017 |
| APOE* E2 allele delays age of onset in PSEN1 E280A Alzheimer’s disease JI Vélez, F Lopera, D Sepulveda-Falla, HR Patel, AS Johar, A Chuah, ... Molecular psychiatry 21 (7), 916-924, 2016 | 121 | 2016 |
| Ascorbic acid acts as an inhibitory transmitter in the hypothalamus to inhibit stimulated luteinizing hormone-releasing hormone release by scavenging nitric oxide S Karanth, WH Yu, A Walczewska, C Mastronardi, SM McCann Proceedings of the National Academy of Sciences 97 (4), 1891-1896, 2000 | 55 | 2000 |
| Ascorbic acid stimulates gonadotropin release by autocrine action by means of NO S Karanth, WH Yu, A Walczewska, CA Mastronardi, SM McCann Proceedings of the National Academy of Sciences 98 (20), 11783-11788, 2001 | 48 | 2001 |
| Association between circulating adipocytokine concentrations and microvascular complications in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of … AJ Rodríguez, V dos Santos Nunes, CA Mastronardi, T Neeman, ... Journal of diabetes and its complications 30 (2), 357-367, 2016 | 71 | 2016 |
| Association between plasma adipocytokine concentrations and microvascular complications in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of … AJ Rodriguez, T Neeman, CA Mastronardi, G Paz-Filho, VS Nunes Clinical Endocrinology, 28-28, 2016 | | 2016 |
| Associations Between Leptin and Diabetic Microvascular Complications: Systematic Review and Meta-Analysis of Cross-Sectional Data GJ Paz-Filho, T Neeman, CA Mastronardi, AJ Rodriguez Diabetes Immunology, Diabetes Complications, THR-610-THR-610, 2015 | | 2015 |
| Candidate biomarkers for systemic inflammatory response syndrome and inflammation: a pathway for novel translational therapeutics CA Mastronardi, J Licinio, ML Wong Neuroimmunomodulation 17 (6), 359-368, 2010 | 5 | 2010 |
| Caspase 1 deficiency reduces inflammation-induced brain transcription C Mastronardi, F Whelan, OA Yildiz, J Hannestad, D Elashoff, ... Proceedings of the National Academy of Sciences 104 (17), 7205-7210, 2007 | 48 | 2007 |
| cGMP signaling, phosphodiesterases and major depressive disorder G W Reierson, S Guo, C Mastronardi, J Licinio, ML Wong Current neuropharmacology 9 (4), 715-727, 2011 | 78 | 2011 |
| Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent GW Reierson, CA Mastronardi, J Licinio, ML Wong Clinical pharmacology: advances and applications, 1-6, 2009 | 7 | 2009 |
Julio LicinioSUNY Distinguished Professor在 upstate.edu 的电子邮件经过验证
